{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:33:30Z","timestamp":1791830010857,"version":"4.3.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jpba.2013.07.041","type":"journal-article","created":{"date-parts":[[2013,8,7]],"date-time":"2013-08-07T18:16:11Z","timestamp":1375899371000},"page":"36-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Quantification of typical antipsychotics in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring"],"prefix":"10.1016","volume":"88","author":[{"given":"Julieta","family":"Gradinaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Vullioud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin B.","family":"Eap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ansermot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2013.07.041_bib0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpba.2013.07.041_bib0010","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/cc11441","article-title":"Therapeutic and toxic blood concentrations of nearly 1000 drugs and other xenobiotics","volume":"16","author":"Schulz","year":"2012","journal-title":"Critical Care"},{"key":"10.1016\/j.jpba.2013.07.041_bib0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00007691-198506000-00016","article-title":"Comparative determination of flupentixol in plasma by gas chromatography and radioimmunoassay in schizophrenic patients","volume":"7","author":"Balant-Gorgia","year":"1985","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.jpba.2013.07.041_bib0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0378-4347(00)84659-9","article-title":"Improved gas chromatographic\u2013mass spectrometric assay for haloperidol utilizing ammonia chemical ionization and selected-ion monitoring","volume":"339","author":"Szczepanik-van Leeuwen","year":"1985","journal-title":"Journal of Chromatography"},{"key":"10.1016\/j.jpba.2013.07.041_bib0025","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.chroma.2011.02.070","article-title":"Quantitative determination of phenothiazine derivatives in human plasma using monolithic silica solid-phase extraction tips and gas chromatography\u2013mass spectrometry","volume":"1218","author":"Kumazawa","year":"2011","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/j.jpba.2013.07.041_bib0030","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1007\/s00216-012-6695-y","article-title":"Determination of seven selected antipsychotic drugs in human plasma using microextraction in packed sorbent and gas chromatography-tandem mass spectrometry","volume":"405","author":"da Fonseca","year":"2013","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/j.jpba.2013.07.041_bib0035","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00216-006-0755-0","article-title":"Determination of haloperidol and reduced haloperidol in human serum by liquid chromatography after fluorescence labeling based on the Suzuki coupling reaction","volume":"386","author":"Kishikawa","year":"2006","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/j.jpba.2013.07.041_bib0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0378-4347(94)00245-2","article-title":"Determination of zuclopenthixol and its main N-dealkylated metabolite in biological fluids using high-performance liquid chromatography with post-column photochemical derivatization and fluorescence detection","volume":"658","author":"Hansen","year":"1994","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/j.jpba.2013.07.041_bib0045","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1570-0232(03)00576-2","article-title":"Simultaneous determination of four antipsychotic drugs in plasma by high-performance liquid chromatography. Application to management of acute intoxications","volume":"795","author":"Garay Garcia","year":"2003","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/j.jpba.2013.07.041_bib0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jchromb.2007.04.004","article-title":"Simple and simultaneous determination for 12 phenothiazines in human serum by reversed-phase high-performance liquid chromatography","volume":"854","author":"Tanaka","year":"2007","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/j.jpba.2013.07.041_bib0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00007691-200104000-00011","article-title":"Therapeutic drug monitoring of haloperidol, perphenazine, and zuclopenthixol in serum by a fully automated sequential solid phase extraction followed by high-performance liquid chromatography","volume":"23","author":"Angelo","year":"2001","journal-title":"Therapeutic Drug Monitoring"},{"key":"10.1016\/j.jpba.2013.07.041_bib0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jchromb.2006.09.019","article-title":"Simultaneous determination of the antipsychotic drugs levomepromazine and clozapine and their main metabolites in human plasma by a HPLC-UV method with solid-phase extraction","volume":"846","author":"Mercolini","year":"2007","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/j.jpba.2013.07.041_bib0065","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0378-4347(96)00294-0","article-title":"Determination of haloperidol and its reduced metabolite in human plasma by liquid chromatography\u2013mass spectrometry with electrospray ionization","volume":"688","author":"Hoja","year":"1997","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/j.jpba.2013.07.041_bib0070","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1515\/CCLM.2003.240","article-title":"Therapeutic drug monitoring of 13 antidepressant and five neuroleptic drugs in serum with liquid chromatography\u2013electrospray ionization mass spectrometry","volume":"41","author":"Gutteck","year":"2003","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1016\/j.jpba.2013.07.041_bib0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jms.440","article-title":"Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography\/mass spectrometry with atmospheric pressure chemical ionization","volume":"38","author":"Kratzsch","year":"2003","journal-title":"Journal of Mass Spectrometry"},{"key":"10.1016\/j.jpba.2013.07.041_bib0080","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jpba.2007.07.022","article-title":"Validation of a sensitive LC\/MS\/MS method for simultaneous quantitation of flupentixol and melitracene in human plasma","volume":"45","author":"Che","year":"2007","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.jpba.2013.07.041_bib0085","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s00216-010-3820-7","article-title":"Fast and simple procedure for liquid\u2013liquid extraction of 136 analytes from different drug classes for development of a liquid chromatographic\u2013tandem mass spectrometric quantification method in human blood plasma","volume":"397","author":"Remane","year":"2010","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/j.jpba.2013.07.041_bib0090","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0731-7085(99)00107-7","article-title":"\u2019High throughput\u2019 solid-phase extraction technology and turbo ionspray LC\u2013MS\u2013MS applied to the determination of haloperidol in human plasma","volume":"20","author":"Hempenius","year":"1999","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.jpba.2013.07.041_bib0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jchromb.2006.05.031","article-title":"Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach","volume":"843","author":"Kirchherr","year":"2006","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/j.jpba.2013.07.041_bib0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jpba.2012.04.016","article-title":"A reliable and rapid tool for plasma quantification of 18 psychotropic drugs by ESI tandem mass spectrometry","volume":"67\u201368","author":"Vecchione","year":"2012","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.jpba.2013.07.041_bib0105","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00216-009-3305-8","article-title":"New trends in fast and high-resolution liquid chromatography: a critical comparison of existing approaches","volume":"397","author":"Guillarme","year":"2010","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/j.jpba.2013.07.041_bib0110","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00216-011-5187-9","article-title":"Ultra high performance liquid chromatographic-tandem mass spectrometric multi-analyte procedure for target screening and quantification in human blood plasma: validation and application for 31 neuroleptics, 28 benzodiazepines, and Z-drugs","volume":"401","author":"Remane","year":"2011","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/j.jpba.2013.07.041_bib0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpba.2012.02.008","article-title":"Simultaneous determination of antidementia drugs in human plasma: procedure transfer from HPLC\u2013MS to UPLC\u2013MS\/MS","volume":"64\u201365","author":"Noetzli","year":"2012","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.jpba.2013.07.041_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2012.12.023","article-title":"Buprenorphine and norbuprenorphine quantification in human plasma by simple protein precipitation and ultra-high-pressure liquid chromatography tandem mass spectrometry","volume":"77","author":"L\u00fcthi","year":"2013","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.jpba.2013.07.041_bib0125","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.chroma.2012.12.071","article-title":"Fast quantification of ten psychotropic drugs and metabolites in human plasma by ultra high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring","volume":"1292","author":"Ansermot","year":"2013","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/j.jpba.2013.07.041_bib0130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0731-7085(93)80157-V","article-title":"Artifacts in the analysis of thioridazine and other neuroleptics","volume":"11","author":"Eap","year":"1993","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/j.jpba.2013.07.041_bib0135","series-title":"Guidance for Industry: Bioanalytical Method Validation","author":"FDA","year":"2001"},{"key":"10.1016\/j.jpba.2013.07.041_bib0140","series-title":"Guideline on Bioanalytical Method Validation","author":"European Medicines Agency","year":"2011"},{"key":"10.1016\/j.jpba.2013.07.041_bib0145","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1208\/aapsj0901004","article-title":"Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays \u2013 Workshop\/Conference Report","volume":"9","author":"Viswanathan","year":"2007","journal-title":"AAPS Journal"},{"key":"10.1016\/j.jpba.2013.07.041_bib0150","first-page":"101","article-title":"Validation of quantitative analytical procedure. Harmonization of approaches","volume":"13","author":"Hubert","year":"2003","journal-title":"STP Pharma Pratiques"},{"key":"10.1016\/j.jpba.2013.07.041_bib0155","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.0.CO;2-0","article-title":"The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds","volume":"13","author":"Bonfiglio","year":"1999","journal-title":"Rapid Communications in Mass Spectrometry"},{"key":"10.1016\/j.jpba.2013.07.041_bib0160","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2013MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Analytical Chemistry"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513003476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708513003476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T03:28:38Z","timestamp":1539487718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708513003476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":32,"alternative-id":["S0731708513003476"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2013.07.041","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of typical antipsychotics in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2013.07.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}